Information  X 
Enter a valid email address

GlaxoSmithKline PLC (GSK)

  Print      Mail a friend       Annual reports

Wednesday 22 October, 2014

GlaxoSmithKline PLC

Re Directorate

RNS Number : 0001V
GlaxoSmithKline PLC
22 October 2014
 



 

 

 

 

Change to Director's Details - Dr Moncef Slaoui

 

GlaxoSmithKline plc (the "Company") today confirms that Dr Moncef Slaoui, an Executive Director, is appointed Chairman, Vaccines, with immediate effect.

 

This appointment will ensure more focused management of the Company's Vaccines business in advance of the completion of the proposed 3 part transaction with Novartis announced earlier this year. Dr Slaoui will continue to provide scientific and technical counsel on pharmaceutical R&D activities to the CEO and Board.

 

Dr Slaoui was previously Chairman, Global R&D and Vaccines.

 

 

V A Whyte

Company Secretary

 

22 October 2014

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAFEWFFEFLSESS

a d v e r t i s e m e n t